Company Description
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.
The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions.
Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
| Country | United States |
| Founded | 1967 |
| IPO Date | Dec 17, 1996 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 48,000 |
| CEO | James E. Davis |
Contact Details
Address: 500 Plaza Drive Secaucus, New Jersey 07094 United States | |
| Phone | (973) 520-2700 |
| Website | questdiagnostics.com |
Stock Details
| Ticker Symbol | DGX |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001022079 |
| CUSIP Number | 74834L100 |
| ISIN Number | US74834L1008 |
| Employer ID | 16-1387862 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| James E. Davis | Chairman, Chief Executive Officer and President |
| Sam A. Samad | Executive Vice President and Chief Financial Officer |
| Michael E. Prevoznik | Senior Vice President and General Counsel |
| Catherine T. Doherty | Executive Vice President of Regional Businesses |
| Karthik Kuppusamy Ph.D. | Senior Vice President of Clinical Solutions |
| Michael J. Deppe | Senior Vice President, Corporate Controller and Chief Accounting Officer |
| Gabrielle Wolfson | Senior Vice President and Chief Information and Digital Officer |
| Shawn C. Bevec | Vice President of Investor Relations |
| Kristin Lee Wallace Esq. | Senior Vice President and Chief Compliance Officer |
| Gary D. Samuels | Senior Vice President and Chief Communications Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 11, 2024 | PX14A6G | Notice of exempt solicitation submitted by non-management |
| Apr 5, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 5, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 25, 2024 | PRE 14A | Other preliminary proxy statements |
| Feb 29, 2024 | 144 | Filing |
| Feb 29, 2024 | 144 | Filing |
| Feb 28, 2024 | 144 | Filing |
| Feb 23, 2024 | 144 | Filing |
| Feb 22, 2024 | 10-K | Annual Report |
| Feb 22, 2024 | 144 | Filing |